Table 1.
Characteristics of the data sources used in the Australian cancer-PAF cohort consortium
| Cohort data | Prevalence data | ||||||||||||
| Characteristic | MCCS | BMES | ALSWH | AusDiab | NWAHS | CHAMP | 45&Up | Pooled | NHS1 | NHS2 | NHS3 | NDSHS | LADY |
| Baseline year(s) | 1990–1994 | 1992–1993 | 1996 | 1999–2000 | 1999–2003 | 2005–2007 | 2006–2009 | 1990–2009 | 2001 | 2004–2005 | 2014–2015 | 2013 | 2013 |
| N | 41 514 | 3654 | 40 310* | 11 247 | 4056 | 1705† | 267 029 | 367 058‡ | 17 918 | 19 501 | 14 560 | 22 696 | 4428 |
| State/territory | VIC | NSW | All | All | SA | NSW | NSW | All | All | All | All | All | All |
| Age at baseline, mean (range) | 55 (27–76) |
66 (45–97) |
45§ (18–75) |
52 (25–95) |
50 (18–90) |
77 (70–97) |
62 (45–≥100) |
59 (18–≥100) |
45 (18–80) |
46 (18–85) |
46 (18–85) |
46 (18–84) |
61 (50–71) |
| Women (%) | 59 | 57 | 100 | 55 | 51 | 0 | 54 | 59 | 51 | 51 | 51 | 51 | 100 |
*1823 women did not consent for record linkage, leaving 38 487 women for the PAF analysis.
†66 men did not consent for record linkage, leaving 1639 men for the PAF analysis.
‡2457 individuals participated in more than one cohort study and were only included in the first cohort study they participated in, leaving 367 058 individuals in the pooled data. Of these, 1885 did not consent for record linkage, leaving 365 173 individuals for the PAF analysis.
§The ALSWH recruited three cohorts aged 18–23, 45–50 and 70–75 so the age distribution is not continuous.
45&Up, 45 and Up Study; ALSWH, Australian Longitudinal Study on Women's Health; AusDiab, Australian Diabetes, Obesity and Lifestyle Study; BMES, Blue Mountains Eye Study; CHAMP, Concord Health and Ageing in Men Project; LADY, Learning how Australians Deal with menopausal sYmptoms Survey; MCCS, Melbourne Collaborative Cohort Study; NDSHS, National Drug Strategy Household Survey; NHS, National Health Survey; NSW, New South Wales; NWAHS, North West Adelaide Health Study; PAF, population attributable fraction; SA, South Australia; VIC, Victoria.